Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Etude Clinique de Phase I de Radiosensibilisation de métastases cérébrales Par Nanoparticules de Gadolinium

NCT02820454 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT02820454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02820454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Etude Clinique de Phase I de Radiosensibilisation de métastases cérébrales Par Nanoparticules de Gadolinium
Lead sponsor
University Hospital, Grenoble
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2016
Completion date
February 28, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases